Nearly 15 years after its controversial drug trial on 200 children with meningitis in Nigeria, Pfizer Inc. and all plaintiffs in the cases related to the trial announced today that they have reached a global settlement. In a joint statement, the parties said, "…the plaintiffs will join the ongoing Healthcare/Meningitis Trust Fund process, which [was initiated by Pfizer and] is being managed by an independent Board of Trustees in Kano, Nigeria. The cases have been amicably resolved after many years of litigation. The settlement will bring an end to all litigation pertaining to Trovan in the United States and Nigeria and allow for just compensation for participants in the study and their families."